WRB W. R. Berkley Corporation
Best-in-class underwriter, but 2.6x book assumes a hard market that is already cresting.
The story
W. R. Berkley is a decentralized specialty and E&S underwriter with disciplined reserving, a mid-80s to low-90s combined ratio, and a short-duration portfolio that is now earning higher reinvestment yields. Trailing ROE of about 20% reflects a hard casualty and E&S market that is maturing: property rates are softening while social-inflation reserve risk is rising. The balance sheet is conservative, but the stock at about 2.56x book already prices peak-like returns.
I raised normalized ROE slightly from 14% to 14.5%. WRB has now held returns near 20% for several years, and higher investment income lifts its through-cycle floor. It is still well below the trailing figure because specialty pricing mean-reverts and reserve charges show up late in the cycle. Book growth, beta and failure risk are unchanged: retention stays high after dividends, the terminal rate is below the 5.18% risk-free rate, and leverage is low.
Value drivers
| Return on equity (normalized) | 14.5% |
| Book-value growth (Y1) | 8.0% |
| Terminal book growth | 4.0% |
| Beta | 0.88 |
| Failure probability | 0.5% |
| Cost of equity | 9.1% |
Valuation bridge
| PV of excess returns | 3.04B |
| PV of terminal excess | 2.81B |
| Equity value | 15.48B |
| ÷ shares → per share | $41.70 |
News
neutral -0.10 · 8 articles
- Arch Capital Lags Industry, Trades at a Discount: Time to Hold or Exit?
- MCY Outperforms Industry in a Year: Time to Buy the Stock for Solid Returns?
- RLI Rises 6.2% in 3 Months: Time to Hold or Fold the Stock?
- W. R. Berkley (WRB) Could Be 17% Undervalued Following Its Dividend Declaration
- How Is W. R. Berkley's Stock Performance Compared to Other Property & Casualty Insurance Stocks?
- WRB's Solid Growth Comes With a Premium Valuation - Hold or Buy?
- CB Stock Trades at 1.62x Book Value: Is the Valuation Worth It?
- Chubb's Middle-Market, Overseas Operations Boost Commercial Growth
Projected excess returns on equity
| Yr | Book equity | ROE | Excess return | PV |
|---|---|---|---|---|
| 1 | 9.70B | 14.5% | 519.58M | 476.05M |
| 2 | 10.48B | 14.1% | 522.07M | 438.26M |
| 3 | 11.27B | 13.8% | 519.50M | 399.56M |
| 4 | 12.07B | 13.4% | 511.44M | 360.41M |
| 5 | 12.87B | 13.0% | 497.53M | 321.23M |
| 6 | 13.68B | 12.6% | 477.49M | 282.46M |
| 7 | 14.47B | 12.3% | 451.14M | 244.52M |
| 8 | 15.24B | 11.9% | 418.38M | 207.76M |
| 9 | 15.98B | 11.5% | 379.24M | 172.55M |
| 10 | 16.69B | 11.1% | 333.85M | 139.17M |
Key risks
- Social inflation driving adverse development on 2019-2023 casualty reserves
- Softening E&S and property pricing compressing underwriting margins
- Mitsui Sumitomo stake-building sustaining a premium multiple the fundamentals do not support, or unwinding it
Catalysts
- Continued favorable reserve releases and sub-90 combined ratios extending the high-ROE run
- Special dividends and buybacks signaling excess capital